On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...